EUCTR2013-001525-10-NL进行中（未招募）不适用
Studying the metabolism of sorafenib (Nexavar®) by OATP1B blockage in adult cancer patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Erasmus MC
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Adults with cancer, in which sorafenib treatment is indicated.
- •- Adequate organ function.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 9
排除标准
- •- Use of other CYP3A4 substrates.
- •- Prior liver transplant.
- •- Patients unable to undergo study procedures.
研究者
相似试验
已完成
不适用
Studying the metabolism of sorafenib (Nexavar®) by OATP1B blockage in adult cancer patientsNL-OMON38631Erasmus MC, Universitair Medisch Centrum Rotterdam9
已完成
不适用
Onderzoek naar het effect van OATP1B blokkade op de stofwisseling van sorafenib (Nexavar®) bij volwassen patiënten met kanker.Solid tumors treated with sorafenib (Nexavar®) mono therapy.NL-OMON23851Erasmus Medical Center; Department of Medical Oncology9
已完成
不适用
The MRS studyCancerTesticular cancerISRCTN56178790Prof. Grzegorz Madej Memorial Foundation Win the health (Fundacja Wygrajmy Zdrowie im Prof. Grzegorza Madeja) (Poland)20
进行中（未招募）
1 期
An exploratory study of sorafenib for patients listed for transplantation due to HCCPatients >18 years with hepatocellular carcinoma, on waiting list for liver transplantationMedDRA version: 12.1Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2010-024306-36-SEVästra Götalandsregionen21
已完成
不适用
Sorafenib pharmacokinetics in non small cell lung cancer patients: an in;vivo study using positron emission tomographylung cancer10038666NL-OMON37648Vrije Universiteit Medisch Centrum12